Boston Trust Walden Corp - ANIKA THERAPEUTICS INC ownership

ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 163 filers reported holding ANIKA THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
Boston Trust Walden Corp ownership history of ANIKA THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$15,299,000
-10.6%
375,070
-0.8%
0.15%
-19.1%
Q4 2020$17,116,000
+28.8%
378,167
+0.7%
0.18%
+10.9%
Q3 2020$13,288,000
-1.8%
375,498
+4.7%
0.16%
-9.8%
Q2 2020$13,526,000
+43.4%
358,482
+9.9%
0.18%
+22.0%
Q1 2020$9,434,000
-17.2%
326,319
+48.4%
0.15%
+12.8%
Q4 2019$11,398,000
-44.1%
219,818
-40.8%
0.13%
-48.0%
Q3 2019$20,397,000
+35.3%
371,596
+0.1%
0.26%
+30.6%
Q2 2019$15,077,000
+89.2%
371,190
+40.9%
0.20%
+81.5%
Q1 2019$7,969,000
-5.0%
263,515
+5.6%
0.11%
-18.8%
Q4 2018$8,386,000
-8.0%
249,537
+15.5%
0.13%
+5.6%
Q3 2018$9,116,000
+24.9%
216,131
-5.2%
0.13%
+17.8%
Q2 2018$7,298,000
-37.2%
228,073
-2.4%
0.11%
-39.2%
Q1 2018$11,621,000
-13.8%
233,735
-6.6%
0.18%
-11.1%
Q4 2017$13,485,000
-9.6%
250,148
-2.8%
0.20%
-14.7%
Q3 2017$14,922,000
+15.4%
257,278
-1.8%
0.23%
+11.5%
Q2 2017$12,926,000
-12.8%
261,992
-23.2%
0.21%
-10.0%
Q1 2017$14,824,000
-60.7%
341,249
-55.7%
0.23%
-22.7%
Q4 2016$37,702,000
+96.7%
770,044
+92.2%
0.30%
-5.4%
Q3 2016$19,171,000
-26.5%
400,644
-17.6%
0.32%
-29.1%
Q2 2016$26,095,000
+18.2%
486,394
-1.5%
0.45%
+16.1%
Q1 2016$22,082,000
+15.8%
493,780
-1.2%
0.38%
+8.5%
Q4 2015$19,062,000
-12.9%
499,537
-27.3%
0.35%
-3.3%
Q3 2015$21,885,000
-2.9%
687,536
+0.8%
0.37%
+6.4%
Q2 2015$22,533,000
-21.8%
682,200
-2.5%
0.34%
-19.6%
Q1 2015$28,801,000
-1.0%
699,562
-2.0%
0.43%
-1.2%
Q4 2014$29,086,000
+99.2%
713,947
+79.3%
0.43%
+92.4%
Q3 2014$14,599,000398,2140.22%
Other shareholders
ANIKA THERAPEUTICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Trigran Investments, Inc. 1,154,183$25,761,0003.00%
CAPITAL MANAGEMENT CORP /VA 275,130$6,141,0001.52%
Kent Lake Capital LLC 98,570$2,200,0001.21%
DIKER MANAGEMENT LLC 21,835$487,0000.60%
Portolan Capital Management 235,972$5,267,0000.53%
Riverwater Partners LLC 12,466$278,0000.28%
Ranger Investment Management 139,661$3,117,0000.24%
Invenomic Capital Management LP 144,287$3,220,0000.23%
CHATHAM CAPITAL GROUP, INC. 23,787$531,0000.12%
Teton Advisors, Inc. 22,000$491,0000.10%
View complete list of ANIKA THERAPEUTICS INC shareholders